Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and efficacy of rivaroxaban-based versus
warfarin-based antithrombotic regimens on outcomes of patients with left ventricle thrombosis
following acute ST elevation myocardial infarction at 3 months from enrollment in an
open-label parallel groups pilot randomized clinical trial